Diversified Consumer Services
Company Overview of University of Texas Southwestern Medical Center - Dallas
University of Texas Southwestern Medical Center - Dallas is an educational institution that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, and other health-care professionals. The schools and colleges of the university include Southwestern Medical School, Southwestern Graduate School of Biomedical Sciences, The Medical Scientist Training Program, Endowed Scholars Program in Medical Science, and Southwestern School of Health Professions. The company was founded in 1943 and is based in Dallas, Texas. The university has endowment assets of $644 million. University of Texas Southwestern Medical Center - Dallas operates as a subsidiary of The Universi...
5323 Harry Hines Boulevard
Dallas, TX 75390
Founded in 1943
Key Executives for University of Texas Southwestern Medical Center - Dallas
Executive Vice President of for Academic Affairs and Dean of UT Southwestern Medical School
Executive Vice President for Clinical Affairs
Executive Vice President of for Business Affairs
Compensation as of Fiscal Year 2016.
University of Texas Southwestern Medical Center - Dallas Key Developments
University of Texas Southwestern Medical Center Presents at Healthcare Analytics 2016, Jul-18-2016 through Jul-19-2016
Jul 15 16
University of Texas Southwestern Medical Center Presents at Healthcare Analytics 2016, Jul-18-2016 through Jul-19-2016. Venue: Chicago, Illinois, United States. Presentation Date & Speakers: Jul-19-2016, DuWayne Willett, Chief Medical Informatics Officer, Kirk Kirksey, Vice President and Chief Information Officer.
Peregrine Pharmaceuticals, Inc. Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from University of Texas Southwestern Medical Center
Jul 14 16
Peregrine Pharmaceuticals, Inc. announced that the company has entered into an exclusive licensing agreement with University of Texas (UT) Southwestern Medical Center for a novel exosome technology that has potential application as a simple blood test to detect or monitor cancer. The company intends to develop a novel cancer test utilizing internal expertise and then pursue revenue-generating partnering opportunities at an early stage of development. Tumor exosomes represent small pieces of tumor cells that are released into the blood as tumors grow. Tumor derived exosomes have phosphatidylserine (PS) on their surface as a detectable marker. It is believed that even small tumors begin to release PS-positive exosomes and thus the ability to detect these exosomes in the blood may be an indicator of the presence of a tumor. The licensing agreement is the result of the long-standing sponsored research agreement between Peregrine and UT Southwestern focused on PS, a highly immunosuppressive signaling molecule. The new technology licensed by Peregrine relates to assays that are able to detect small amounts of PS-exosomes in a patient blood sample as a way to potentially detect cancer at a very early stage of development. Preliminary studies have demonstrated that the levels of PS-positive exosomes present in the blood of cancer patients are higher than levels found in the blood of healthy volunteers. Furthermore, study findings also suggest that there is a correlation between the level of PS-positive exosomes detected in the blood of cancer patients and disease burden. Together, the Peregrine and Avid Bioservices teams have the existing infrastructure, staff and expertise to develop, optimize and validate a functional assay capable of detecting PS-positive exosomes from a blood sample. Given the company’s extensive experience in developing assays of this type, Peregrine does not anticipate the need to add personnel or any specialized equipment for this project. The company intends to establish clinical proof-of-concept for the test and expects to initiate partnering discussions for the program in 2017.
UT Southwestern Medical Center's New $17 Million Cryo-Electron Microscope Center Provides Extraordinary Views of Life at Atomic Scale
May 11 16
UT Southwestern Medical Center has announced the opening of a new $17 million cryo-electron microscope (cryo-EM) facility housing a unique collection of instruments that researchers can use to view 3-D images of objects as tiny as an atom all the way up to intact cells. The facility's three cutting-edge instruments – a Titan Krios, a Talos Arctica, and a Scios DualBeam for thin-slice cryo-electron tomography – are expected to provide the technologies to help accelerate UT Southwestern's biomedical investigations on everything from cancer biology to drug discovery and will run 24 hours a day, seven days a week. These instruments will analyze specimens that have been rapidly frozen to prevent the formation of damaging ice crystals. The specimens will then be viewed in special holders under conditions that keep them at cryogenic temperatures (minus 321 degrees Fahrenheit). The three advanced instruments and the special climate- and humidity-controlled, vibration-protected building to house them received funding from an anonymous donor, UT Southwestern, the Cancer Prevention and Research Institute of Texas (CPRIT), the UT System's Science and Technology Acquisition and Retention program, and the Howard Hughes Medical Institute (HHMI).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|